Bridget Lamonica Ostrem MD PhD (She/Her)
Neuroimmunology/Multiple Sclerosis, Neurodevelopmental Disabilities, Child Neurology
Physician
Pediatric Brain Center1825 4th St Floor 5San Francisco, CA 94158
Overview of Dr. Ostrem
Dr. Ostrem is a Pediatric Neurologist with expertise in Maternal-Fetal and Neonatal Neurology. She completed the Medical Scientist Training Program at UCSF in the laboratory of Dr. Arnold Kriegstein, followed by residency in Pediatric Neurology in the Mass General Brigham Program in Boston, Massachusetts, and clinical fellowship in Women's Neurology at Brigham and Women's Hospital. She also completed a postdoctoral fellowship in the laboratory of Dr. Paola Arlotta at Harvard. Dr. Ostrem's research focuses on developing novel strategies for neuroprotection and repair in the fetal and neonatal brain, and understanding how maternal factors impact brain development. In her clinic, she treats neurological conditions in babies, children, young adults, and pregnant patients.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2017 - 2020
Boston Children’s Hospital/Boston Medical CenterInternship, Pediatrics, 2016 - 2017
University of California San Francisco School of MedicineClass of 2016, MD
Certifications & Licensure
CA State Medical License 2022 - 2026
MA State Medical License 2018 - 2023
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Publications & Presentations
PubMed
- 1 citationsMinimum effective dose of clemastine in a mouse model of preterm white matter injury.Elizabeth P Odell, Nora Jabassini, Björn Schniedewind, Sarah E Pease-Raissi, Adam Frymoyer
Pediatric Research. 2024-09-01 - ECI biocommentary: Bridget Ostrem.Bridget E L Ostrem
Pediatric Research. 2024-09-01 - 2 citationsMonogenic Causes of Cerebrovascular Disease in Childhood: A Case Series.Bridget E L Ostrem, Deena Godfrey, Paul A Caruso, Patricia L Musolino
Pediatric Neurology. 2023-12-01
Press Mentions
Can This Medication Reverse MS? Brain Biomarker Shows It CanJune 14th, 2023- Antihistamine Sparks Hope for Myelin Repair in Multiple SclerosisJune 14th, 2023
- Promising Results for Antihistamine as Potential MS TreatmentJune 14th, 2023
Grant Support
- Investigating the therapeutic potential of maternal breast milk components for preterm white matter injuryUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
